Available evidence indicates no harm, but no significant benefit, with stereotactic radiosurgery (SRS) for cerebral cavernous malformations (CCM), but more data are needed.
Why this matters
Current treatment of CCM typically includes conservative treatment (CON), microsurgical excision (ME), or SRS.
The role of SRS in CCM management is unclear.
Current information on the relative benefit of SRS may inform clinicians’ decisions regarding its use.